openPR Logo
Press release

Uterine Fibroids Pipeline Assessment growing over the forecast years 2019-2025

02-20-2019 01:52 PM CET | Health & Medicine

Press release from: Precision Business Insights

Uterine Fibroids Pipeline Assessment

Uterine Fibroids Pipeline Assessment

Uterine Fibroids Pipeline Assessment is Rising due to High investments for the R&D Activities
Analyst Speak:

“The Uterine Fibroids Pipeline Assessment growing over the forecast years 2019-2025 owing to grow in R&D activities by the market players”

The uterine fibroids pipeline assessment increasing over the forecast years due to surge in the prevalence of uterine fibroid cases in female coupled with increase in the R&D activities for the development of newer drugs by the various pharmaceutical and biopharmaceutical companies. Moreover, patent expiries of block buster drugs, and fund raising public and private sectors for the development R&D activities are propel the uterine fibroids pipeline assessment over the forecast years. However, stringent regulatory guidelines, high R&D cost for the development of newer therapeutics and adverse effects with the newer therapeutics, hinder the uterine fibroids pipeline assessment over the forecast timeframe

Uterine Fibroids Pipeline Assessment market segmented on the basis of clinical phase, route of administration, and region. Based on clinical phase, uterine fibroid drugs are segmented into Phase I, Phase II, Phase III, and Phase IV therapeutics. Based on the route of administration, the market is segmented into oral, vaginal, and others.

A sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/uterine-fibroids-pipeline-drugs-assessment/#ulp-4H8Z4LpNMLEuOnnx

Most of the companies are present in the Phase III clinical trials with positive efficacy and safety results in the treatment of uterine fibroid treatment. For instance, In October 2017, Takeda Pharmaceuticals partnered with Myovant and announced the positive Phase III clinical studies results in the development of Relugolix, a uterine fibroid treatment drug. Moreover, AbbVie, Inc. and Neurocrine Biosciences collaborated in the development of uterine fibroid treatment drug Elagolix and announced the second positive Phase III clinical trial studies in March 2018.

To view TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/uterine-fibroids-pipeline-drugs-assessment/#ulp-c654SbFYO64MsOhu

Key player’s profiles in the report are Repros Therapeutics Inc. (U.S.), Bayer AG (Germany), Takeda Pharmaceutical Company Ltd (Japan), AbbVie Inc. (U.S.), KISSEI PHARMACEUTICAL CO.,Ltd. (Japan), BioSpecifics Technologies Corporation (U.S.), and DONGKOOK Pharmaceutical Co., Ltd (Japan)

Precision Business Insights (PBI) in its report titled “Uterine Fibroids Pipeline Assessment”: Clinical Trails Analysis, Collaborations, Key Targets, Geographic Focus, and Data Publications, Competitor Analysis 2018. The report also covers therapeutics under Development by Companies/Institutes/Universities, the molecules in Pre-Registration, Filing rejected/withdrawn, Phase I, Phase II, Phase III, IND/CTA Filed, Preclinical, and Discovery

Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/uterine-fibroids-pipeline-drugs-assessment/#ulp-14mlyhjMGhVjZqa3

Detailed Segmentation

By Clinical Trial Phase
o Pre-clinical phase
o Phase-I
o Phase II
o Phase-III
By Route of Administration
o Oral
o Vaginal
o Others
Geography
o North America
• U.S
• Canada
o Europe
• Germany
• France
• U.K
• Italy
• Spain
• Russia
• Poland
• Rest of Europe
o Asia-Pacific
• Japan
• China
• India
• Australia & New Zealand
• ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
• South Korea
• Rest of Asia-Pacific
o Latin America
• Brazil
• Mexico
• Argentina
• Venezuela
• Rest of Latin America
o Middle East and Africa (MEA)
• Gulf Cooperation Council (GCC) Countries
• Israel
• South Africa
• Rest of MEA

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/uterine-fibroids-pipeline-drugs-assessment/

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,
152 – 160 City Road,
London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Uterine Fibroids Pipeline Assessment growing over the forecast years 2019-2025 here

News-ID: 1603789 • Views: 277

More Releases from Precision Business Insights

Corporate Training Market Segments, Top Key Players, Drivers And Trends 2022
Precision Business Insights published a research report on "Corporate Training Market: By Training Type (Classroom, E-Learning & Webcast), By End User (Software & Technology, Healthcare, Retail, Bank, Finance, & Insurance, Manufacturing, Government & Defense, Telecom & Others) - Global/Region/Country Forecast to 2028" In recent years, corporate training has evolved significantly to include more than simply new employees, salespeople, and leaders. Corporate trainers and learning and development specialists are viewed as commercial
UK Private Healthcare Market Business Opportunities And Regional Outlook 2022
Precision Business Insights published a research report on "UK Private Healthcare Market : By Service Type (Private Acute Care Hospitals, Private Patient Care Clinics, Private Specialist Services, Private Diagnostics and Imaging Centers, Private Urgent Care Centers, and Others), By Specialty (Trauma and Orthopedics, General Surgery, Oncology, Maternity and OB-Gyn, Cardiology, Urology, and Others), End Users (International Tourists, NHS Referrals & PMI, and Self-pay Individuals) - Global/Region/Country Forecast to 2028" A
Rice Bran Oil Market | Size, Growth, Trends And Forecast 2022-28
Precision Business Insights published a research report on "Rice Bran Oil Market: By Application (Food & Beverages, Cosmetics, Others), By End User (Super & Hyper Markets, E-Commerce, Others) - Global/Region/Country Forecast to 2028" Rice bran oil is an edible vegetable oil derived from the rice's outer brown coat. It is high in vitamin E, antioxidants, & natural bioactive phytoceuticals such oryzanol, tocopherols, tocotrienols, as well as lecithin, and has a moderate
Pneumatic Tools Market Size, Share, Growth | Global Report 2028
Precision Business Insights published a research report on "Pneumatic Tools (Hammers & Drills) Market: By Product Type [Hammers (Pneumatic Hammer, Hydraulic Hammer, Concrete Hammer), Drills (Hand held Surface Rock drill, Drill Rigs & Cluster Drills)] - Global/Region/Country Forecast to 2028" Compressed air (as it works by the force of air) powers pneumatic tools; compressed air is supplied by an air compressor. To put it another way, pneumatic devices are driven by

All 5 Releases


More Releases for Phase

2026 Global Pharmacovigilance Market Growth Analysis by Clinical Trials Like Pre …
Global Pharmacovigilance Market 2018 report includes extensive Market analysis and industry landscape along with SWOT analysis and PESTEL analysis of the important vendors. The analysis is conducted with a blend of secondary and primary advice for inputs from participants in the industry. Pharmacovigilance industry report covers the prospects of Women’S Health P oducts in the forecast period of 2018-2026 and the scenario. Growing prevalence of adverse reactions caused by drugs, has
Reverse Phase Columns (Professional Survey Report 2017)
"Global Reverse Phase Columns Market Professional Survey Report 2017" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. . . Description- '
MAAT Inaugurates Versatile Phase Shifter
Company announces release of a digital recreation of Roger Schult’s analog hardware MAAT Incorporated, a manufacturer of exceptional performance professional audio solutions, today announced the release of RSPhaseShifter version 1.0, a digital implementation of the Roger Schult/German Audio Lab’s Phase Shifter 500 Series W2324 hardware. The cross–platform plug–in creates a high quality, phase shifted version of a monaural or stereo input. Available in formats for all major DAWs (Digital Audio Workstations), RSPhaseShifter
Pre-Registration, Filing Rejected/Withdrawn, Phase Iii, Phase Ii, Phase I, Precl …
"Migraine - Pipeline Review, H2 2016" The Report covers current Market Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Migraine Pipeline Review, H2 2016, provides an overview of the Migraine (Central Nervous System) pipeline landscape. Migraine is a disorder characterized by repeated attacks of severe headache. A migraine headache causes throbbing or pulsating pain, usually on only one side of
Daisho Blacksmith completes successful Beta Test Phase
Huge support from users by brisk participation at beta test • Sync release could be further optimized • Official sync release shortly available as download Munich, february 23rd 2011. The beta test for the new version of the personal information management software DAISHO was successfully completed. Daisho Blacksmith, developer of the PIM tool, would like to thank the numerous testers which have actively contributed to the enhancement of DAISHO through their dedicated testing.
Epsilon Award 2008 - Nomination phase has started
The Epsilon Award is a combination of Excellency, craftsmanship and visionary ability. These are characteristics of an outstanding programmer and a piece of true software art. And you can now send your application for nomination for this prestigious award of our software industry. Please read all details and find the relevant signup link www.euroconference.org/Epsilon_Vote.htm on the webportal of the European Software Conference 2008, taking place in Berlin on November 8